119 related articles for article (PubMed ID: 8319499)
1. Immunohistochemical demonstration of mutant p53 tumour suppressor gene product in aberrant crypt foci.
Stopera SA; Bird RP
Cytobios; 1993; 73(293):73-88. PubMed ID: 8319499
[TBL] [Abstract][Full Text] [Related]
2. Altered expression of beta-catenin, inducible nitric oxide synthase and cyclooxygenase-2 in azoxymethane-induced rat colon carcinogenesis.
Takahashi M; Mutoh M; Kawamori T; Sugimura T; Wakabayashi K
Carcinogenesis; 2000 Jul; 21(7):1319-27. PubMed ID: 10874009
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical expression of mutant p53 oncogene in transitional mucosa adjacent to human colon cancer.
Baytner S; Mitmaker B; Gordon PH; Wang E
Clin Invest Med; 1993 Oct; 16(5):379-85. PubMed ID: 8261691
[TBL] [Abstract][Full Text] [Related]
4. Qualitative and quantitative relationship between dysplastic aberrant crypt foci and tumorigenesis in the Min/+ mouse colon.
Paulsen JE; Steffensen IL; Løberg EM; Husøy T; Namork E; Alexander J
Cancer Res; 2001 Jul; 61(13):5010-5. PubMed ID: 11431334
[TBL] [Abstract][Full Text] [Related]
5. Frequent beta-catenin gene mutations and accumulations of the protein in the putative preneoplastic lesions lacking macroscopic aberrant crypt foci appearance, in rat colon carcinogenesis.
Yamada Y; Yoshimi N; Hirose Y; Kawabata K; Matsunaga K; Shimizu M; Hara A; Mori H
Cancer Res; 2000 Jul; 60(13):3323-7. PubMed ID: 10910031
[TBL] [Abstract][Full Text] [Related]
6. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous exposure to dietary acrylamide and corn oil developed carcinogenesis through cell proliferation and inhibition of apoptosis by regulating p53-mediated mitochondria-dependent signaling pathway.
Zhang X
Toxicol Ind Health; 2009 Mar; 25(2):101-9. PubMed ID: 19458132
[TBL] [Abstract][Full Text] [Related]
8. Role of the alternating reading frame (P19)-p53 pathway in an in vivo murine colon tumor model.
Nambiar PR; Giardina C; Guda K; Aizu W; Raja R; Rosenberg DW
Cancer Res; 2002 Jul; 62(13):3667-74. PubMed ID: 12097273
[TBL] [Abstract][Full Text] [Related]
9. Genetic signatures of high- and low-risk aberrant crypt foci in a mouse model of sporadic colon cancer.
Nambiar PR; Nakanishi M; Gupta R; Cheung E; Firouzi A; Ma XJ; Flynn C; Dong M; Guda K; Levine J; Raja R; Achenie L; Rosenberg DW
Cancer Res; 2004 Sep; 64(18):6394-401. PubMed ID: 15374946
[TBL] [Abstract][Full Text] [Related]
10. K-ras mutations in aberrant crypt foci, adenomas and adenocarcinomas during azoxymethane-induced colon carcinogenesis.
Vivona AA; Shpitz B; Medline A; Bruce WR; Hay K; Ward MA; Stern HS; Gallinger S
Carcinogenesis; 1993 Sep; 14(9):1777-81. PubMed ID: 8403199
[TBL] [Abstract][Full Text] [Related]
11. An evaluation of six antibodies for immunohistochemistry of mutant p53 gene product in archival colorectal neoplasms.
Baas IO; Mulder JW; Offerhaus GJ; Vogelstein B; Hamilton SR
J Pathol; 1994 Jan; 172(1):5-12. PubMed ID: 7931827
[TBL] [Abstract][Full Text] [Related]
12. Histochemical studies of progressive p53 mutations during colonic carcinogenesis in Sprague-Dawley rats induced by N-methyl-N-nitro-nitrosoguanidine or azoxymethane.
Tendler Y; Reshef R; Cohen I; Barzilai M; Shasha SM; Rotter V; Shkolnik T
Pathobiology; 1994; 62(5-6):232-7. PubMed ID: 7598792
[TBL] [Abstract][Full Text] [Related]
13. Tea can protect against aberrant crypt foci formation during azoxymethane induced rat colon carcinogenesis.
Sengupta A; Ghosh S; Das S
J Exp Clin Cancer Res; 2003 Jun; 22(2):185-91. PubMed ID: 12866568
[TBL] [Abstract][Full Text] [Related]
14. Molecular changes in the early stage of colon carcinogenesis in rats treated with azoxymethane.
Kishimoto Y; Morisawa T; Hosoda A; Shiota G; Kawasaki H; Hasegawa J
J Exp Clin Cancer Res; 2002 Jun; 21(2):203-11. PubMed ID: 12148579
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic acid and F(6)-D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin.
Wali RK; Khare S; Tretiakova M; Cohen G; Nguyen L; Hart J; Wang J; Wen M; Ramaswamy A; Joseph L; Sitrin M; Brasitus T; Bissonnette M
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1653-62. PubMed ID: 12496057
[TBL] [Abstract][Full Text] [Related]
16. Evidence for a ras gene mutation in azoxymethane-induced colonic aberrant crypts in Sprague-Dawley rats: earliest recognizable precursor lesions of experimental colon cancer.
Stopera SA; Murphy LC; Bird RP
Carcinogenesis; 1992 Nov; 13(11):2081-5. PubMed ID: 1423879
[TBL] [Abstract][Full Text] [Related]
17. Chemopreventive effect of a probiotic preparation on the development of preneoplastic and neoplastic colonic lesions: an experimental study.
Marotta F; Naito Y; Minelli E; Tajiri H; Bertuccelli J; Wu CC; Min CH; Hotten P; Fesce E
Hepatogastroenterology; 2003; 50(54):1914-8. PubMed ID: 14696432
[TBL] [Abstract][Full Text] [Related]
18. Effect of vaccination with mutant KRAS peptides on rat colon carcinogenesis induced by azoxymethane.
Paulsen JE; Bjørheim J; Røe J; Eide TJ; Alexander J; Gaudernack G
Anticancer Res; 2002; 22(1A):171-5. PubMed ID: 12017282
[TBL] [Abstract][Full Text] [Related]
19. [Immunochemical evidence of a mutated p53 protein expressed in human colorectal adenocarcinoma].
Hammel PR; Beuvon FX; Salmon RJ; Remvikos Y
Gastroenterol Clin Biol; 1991; 15(6-7):529-35. PubMed ID: 1916131
[TBL] [Abstract][Full Text] [Related]
20. Diosgenin, a steroid saponin of Trigonella foenum graecum (Fenugreek), inhibits azoxymethane-induced aberrant crypt foci formation in F344 rats and induces apoptosis in HT-29 human colon cancer cells.
Raju J; Patlolla JM; Swamy MV; Rao CV
Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1392-8. PubMed ID: 15298963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
